YANTAI, China--(BUSINESS WIRE)--Bohai Pharmaceuticals Group, Inc. (OTCBB: BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine in China, today announced an expansion of its management team, which now includes Gene Hsiao, former Chief Financial Officer for China Advanced Construction Materials Group, Inc. (NASDAQ: CADC), as Bohai’s new Chief Financial Officer.
